Research Associate II, Molecular Biology

Description

Alector is a biopharmaceutical company founded in 2013 that focuses on developing therapies to combat neurodegenerative diseases. The company's innovative approach harnesses the power of the immune system to target dysfunctional pathways in the brain, with the goal of addressing diseases such as Alzheimer's and Parkinson's. Alector's groundbreaking research and development efforts are paving the way for potential breakthrough treatments in the field of neuroscience.